Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Moodys
Accenture
Cerilliant
Colorcon
Federal Trade Commission
UBS
Mallinckrodt
Boehringer Ingelheim

Generated: January 24, 2018

DrugPatentWatch Database Preview

CISATRACURIUM BESYLATE Drug Profile

« Back to Dashboard

When do Cisatracurium Besylate patents expire, and when can generic versions of Cisatracurium Besylate launch?

Cisatracurium Besylate is a drug marketed by Accord Hlthcare, Fresenius Kabi Usa, Jiangsu Hengrui Med, and Sandoz Inc. and is included in eight NDAs.

The generic ingredient in CISATRACURIUM BESYLATE is cisatracurium besylate preservative free. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cisatracurium besylate preservative free profile page.
Summary for CISATRACURIUM BESYLATE
Drug patent expirations by year for CISATRACURIUM BESYLATE
Pharmacology for CISATRACURIUM BESYLATE

US Patents and Regulatory Information for CISATRACURIUM BESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 205873-001 Jun 16, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 203182-001 Feb 26, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 200159-001 Feb 3, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 200154-002 Feb 3, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 203182-002 Feb 26, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 203183-001 Feb 26, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jiangsu Hengrui Med CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 209334-001 Aug 30, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 205872-002 Jun 16, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 205872-001 Jun 16, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jiangsu Hengrui Med CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate preservative free INJECTABLE;INJECTION 204960-002 Sep 19, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Baxter
Argus Health
Harvard Business School
Mallinckrodt
Accenture
Chinese Patent Office
Deloitte
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot